Medical Innovation Exchange

With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.